Back to User profile » Dr Allahyar Janjua
Paper published by Dr Allahyar Janjua:
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Phase II trial of second-line erlotinib and digoxin for nonsmall cell lung cancer (NSCLC)
Fadi Kayali, Muhamad A Janjua, Damian A Laber, Donald Miller, Goetz H Kloecker
Open Access Journal of Clinical Trials 2011, 3:9-13
Published Date: 6 February 2011